SCHEMBL26077350

SCHEMBL26077350

COC(=O)c1cc(Oc2ccc(N3CCCCC3)nc2)nc(Cl)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ P2RX3 P56373 1/20 0.42
▸ NFKB1 P19838 2/20 0.41
▸ NR2C2 P49116 2/20 0.41
▸ NFKB2 Q00653 2/20 0.41
▸ RELA Q04206 2/20 0.41
▸ TAB1 Q15750 2/20 0.41
▸ CSF1R P07333 1/20 0.40
▸ DAPK1 P53355 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ FURIN P09958 5/20 0.39
▸ CACNA1H O95180 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ CNR2 P34972 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26077351 0.86 FURIN (0.44) ALDH1A1NFKB1NR2C2NFKB2RELA
SCHEMBL21551285 0.85 GPR119 (0.49) TSHRKMT2A
SCHEMBL30931776 0.85 GPR119 (0.49) TSHRKMT2A
SCHEMBL26077220 0.83 GPR119 (0.51) ALDH1A1CSF1RDAPK1TSHRNPSR1
SCHEMBL26077221 0.79 FURIN (0.51) ALDH1A1CSF1RDAPK1TSHRNPSR1
SCHEMBL3412871 0.78 SMN1; SMN2 (0.41) ALDH1A1TSHRNPSR1NPC1RAB9A
SCHEMBL2178736 0.77 LMNA (0.40) ALDH1A1TSHRNPSR1NPC1RAB9A
SCHEMBL26077248 0.74 RAB9A (0.43) ALDH1A1CSF1RDAPK1TSHRNPSR1
SCHEMBL21550824 0.73 GPR119 (0.45) FURIN
SCHEMBL7326778 0.70 RAB9A (0.71) ALDH1A1NPSR1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 ALDH1A1 3733/4885P2RX3 4512/4885NFKB1 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback